Clearpoint Neuro, Inc. (CLPT)
12.98
-0.13
(-0.99%)
USD |
NASDAQ |
Dec 11, 16:00
13.35
+0.37
(+2.85%)
After-Hours: 20:00
Clearpoint Neuro Cash from Financing (Quarterly): 0.00 for Sept. 30, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | -10.24M |
| Masimo Corp. | -218.40M |
| Perspective Therapeutics, Inc. | 0.213M |
| Xtant Medical Holdings, Inc. | -5.771M |
| VolitionRX Ltd. | 1.461M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.121M |
| Cash from Investing (Quarterly) | -0.199M |
| Free Cash Flow | -13.82M |
| Free Cash Flow Per Share (Quarterly) | -0.1168 |
| Free Cash Flow to Equity (Quarterly) | -3.609M |
| Free Cash Flow to Firm (Quarterly) | -2.776M |
| Free Cash Flow Yield | -3.80% |